Description

SEBI issues a final order against Dr. Rashmi Saluja for suspected insider trading in Religare Enterprises Ltd. (REL) while allegedly in possession of unpublished price sensitive information (UPSI) related to an open offer by the Burman Group.

Summary

SEBI has issued a final order (WTM/KV/IVD-1/ID16/32405/2026-27) against Dr. Rashmi Saluja (PAN: AUVPS5660D) under Sections 11(1), 11(4), 11(4A), 11B(1), and 11B(2) of the SEBI Act, 1992, read with Rule 5 of the SEBI (Procedure for Holding Inquiry and Imposing Penalties) Rules, 1995. The order pertains to suspected insider trading in the scrip of Religare Enterprises Ltd. (REL) while allegedly in possession of Unpublished Price Sensitive Information (UPSI) concerning an open offer by the Burman Group announced on September 25, 2023.

Key Points

  • The matter was initiated following an email dated November 08, 2023, from the Burman Group (comprising M.B. Finmart Pvt Ltd, Puran Associates Pvt Ltd, VIC Enterprises Pvt Ltd, and Milky Investment & Trading Company), requesting SEBI to examine trades by Dr. Rashmi Saluja in REL.
  • SEBI investigated whether Dr. Rashmi Saluja was an ‘insider’ under Regulation 2(1)(g) of the PIT Regulations, 2015, either as a connected person or as someone in possession of or having access to UPSI.
  • The UPSI relates to the Burman Group’s open offer to public shareholders of REL, announced on September 25, 2023.
  • The order examines three core issues: (i) insider status, (ii) trading while in possession of UPSI, and (iii) whether directions and/or penalties are warranted.
  • The order spans 87 pages and includes a detailed computation of wrongful gain (loss avoided).
  • A Show Cause Notice (SCN) was issued; the process included inspection, cross-examination, and hearing.

Regulatory Changes

No new regulatory changes are introduced. The order applies existing provisions of the SEBI Act, 1992 and the SEBI (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations).

Compliance Requirements

  • Market participants, especially directors and senior executives of listed companies, must strictly refrain from trading in company scrip while in possession of UPSI.
  • Connected persons (as defined under PIT Regulations) must be aware of their obligations and trading restrictions during periods when UPSI exists.
  • Companies must maintain robust internal controls to prevent insider trading and ensure timely disclosure of price-sensitive information.

Important Dates

  • October 26, 2023: Letter by Burman Group to REL Board of Directors regarding trades by Dr. Rashmi Saluja.
  • September 25, 2023: Date of the open offer announcement by Burman Group (the UPSI event).
  • November 08, 2023: Burman Group’s email to SEBI requesting examination of trades.
  • 2026-27: Order reference year (WTM/KV/IVD-1/ID16/32405/2026-27).

Impact Assessment

This is a significant enforcement action by SEBI targeting insider trading at the senior executive level in a high-profile listed company. The order reinforces SEBI’s commitment to market integrity and zero tolerance for trading on UPSI. For investors in REL, the order may have implications for corporate governance perceptions. The computation of wrongful gain and imposition of directions/penalties under the SEBI Act signals that SEBI is actively pursuing disgorgement of illegal profits in insider trading cases. Market participants should treat this as a strong deterrent and review internal compliance frameworks around UPSI identification, trading windows, and connected-person registers.

Impact Justification

High-profile final enforcement order against a senior corporate figure (Dr. Rashmi Saluja) for insider trading in REL, involving UPSI related to a major open offer by the Burman Group. The 87-page order includes computation of wrongful gains and directions/penalties under the SEBI Act, signalling strong regulatory action.